`Document Description: TrackOne Request
`
`;PTOVAIA424 (04-14)
`
`CERTIFICATION AND REQUEST FOR PRIORITIZED EXAMINATION
`UNDER 37 CFR 1.102(e} Page 1 of 1)
`
`First Named
`inventor:
`
`:
`Nonprovisional Application Number (if
`Herewith
`known):
`Jeroen Poeze
`MULTI-STREAM DATA COLLECTION SYSTEM FOR NONINVASIVE MEASUREMENT OF BLOOD CONSTITUENTS
`
`APPLICANT HEREBY CERTIFIES THE FOLLOWING AND REQUESTS PRIORITIZED EXAMINATION FOR
`THE ABOVE-IDENTIFIED APPLICATION.
`
`1. The processing fee set forth in 37 CFR 1.174)(1) and the prioritized exarnination fee set forth in
`37 CFR 1.17(c) have been filed with the request. The publication fee requirement is met
`because that fee, set forth in 37 CFR 1.48(d), is currently 50. The basic filing fee, search fee,
`and examination fee are filed with the request or have been already been paid.
`| understand
`that any required excess claims fees or application size fee must be paid for the application.
`
`| understand that the application may not contain, or be amended to contain, more than four
`independent claims, more than thirtytotal claims, or any multiole dependent claims, and that
`any requesi for an extension of time will cause an outstanding Track i request fo be dismissed.
`
`3. The applicable box is checked below:
`
`lication (Track One} - Prioritized Examination under
`
`(a) The application is an original nonprovisional utility application filed under 35 U.S.C. 111(a).
`This certification and request is being filed with the utility application via EFS-Wehb.
`
`(b} The application is an original nonprovisional plant application filed under 35 U.S.C. 17 14a).
`This certification and request is being filed with the plant application in paper.
`
`An executed invertors oath er declaration under 37 CFR 1.63 or 37 CFR 1.64 for each
`inventor, or ihe application data sheet meeting the conditions specified in 37 CFR 1.53) (3)()is
`filed with the application.
`
`A request for continued examination has been filec with, or prior to, this form.
`ifthe application is a ulliity application, this certification and request is being filed via EFS-Veb.
`ii. The application is an onginal nonprovisional utility application filed under 35 U.S.C. 111 fa), or is
`a national siage entry under 35 U.S.C, 371.
`iv. This certification and request is being filed prior to the mailing of a first Office action responsive
`to the request for continued examination.
`No prior request for continued examination has been granted pricrilized examination status
`under 37 CFR 4.102(e)(2)}.
`
`(PrinlTyped
`
`Registration Number
`
`forms are submmitied.
`
`‘Scott Cromar/
`“pae2018-12-06
`
`Signature
`Mare (Practitoner|65066eg WCOtL Cromar
`
`
`
`
`This form must be signed in accordance with 37 CFR 71.33. See 37 CFR 1.4(d) for signature requirements and certifications.
`Note:
`Submit muitioie forms if more than ene signature is required. *
`
`5
`
`*Total af 4
`
`1
`
`APPLE 1002
`
`1
`
`APPLE 1002
`
`
`
`Privacy Act Statement
`
`The Privacy Act of 1974 (P.L. 93-878) requires that you be given certain information in connection with your
`submission of the attached form related to a patent application or patent. Accordingly, pursuant to the requirements of
`the Act, please be advised thai: (1) the general authorily for the collection of this information is 35 U.S.C. 2(b}(2}; (2)
`furnishing of the information solicited is yvoluniary; and @) the principal purpose for which the information is used by the
`U.S. Patent and Trademark Office is to process and/or examine your submission related io a patent application or
`patent. H you de not furnish the requested information, the U.S. Patent and Trademark Office may not be able ic
`process and/or examine your submission, which may result in termination of proceedings or abandonment of the
`application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1.
`
`~
`
`The information on this form will be treated confidentially to the extent allowed under the Freedom of
`information Act (6 U_S.C. 552) and the Privacy Act (5 U.S.C 552a). Records fromthis systemof records may
`be disclosed to the Department of Justice to determine whether disclosure of these records is required by the
`Freedomof Iniormation Act.
`A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence
`to a court, magisiraie, or administrative tribunal, including disclosures to opposing counsel in ihe course of
`settlement negotiations.
`A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting a
`request involving an individual, to wham the record pertains, when the individual has requested assistance from
`ihe Memberwith respect to the subject matter of the record.
`A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency having
`need for the informaiton tn order to perform a contract. Recipients of information shail be required io comply
`with the requirements of the Privacy Act of 1974, as amended, pursuantto 5 U.S.C. 8S2a(m).
`A record related to an Infernational Application filed under the Patent Cooperation Treaty in this systern of
`records may Ge disclosed, a5 4 routine use, to the International Bureau of the World Intellectual Property
`Organization, pursuant io the Patent Cooperation Treaty.
`A record in this system of records may be disclosed, as a routine use, to another federal agency for purposes
`of National Security review (5 U.S.C. 181) and for review pursuant te the Atomic Energy Act (42 U.S.C.
`278%}.
`A record from this sysiemof records may be disclosed, as a routine use, to the Administraior, Generai
`Services, or his/her designee, during an inspection of records conducted by GSA as part of that agency’s
`responsibility to recommend improvements in records management practices and programs, under authority of
`44 U.S.C. 2904 and 2906. Such disclosure shall be made in accordance with the GSA regulations governing
`inspection of records for this purpose, and any other relevant (.¢., GSA or Commerce) directive. Such
`disclosure shall not be used io make determinations about individuals.
`A record from this sysiemof records may be disclosed, as a routine use, to the public afler eilher publication of
`ihe application pursuant io 35 U.S.C. 122(b} or issuance of a patent pursuant ic 35 U.S.C. 151. Further, a
`record may be disclosed, subject ic the limitations of 37 CFR 1.14, as a routine use, to ihe public ifthe recerd
`was filed in an application which became abandoned or in which the proceedings were terminated and which
`application is referenced by either a published application, an application open to public inspection or an issued
`patent.
`A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law
`enforcement agency, ifthe USPTO becomes aware of a viclalion or potential violation of law or reguiation.
`
`2
`
`
`
`Doc Code: PA...
`PTO/ALAIBZA (07-13)
`Approved for use through 11/30/2614. OMB 0854-0054
`Document Description: Power of Aitorney
`US. Patent and Trademark Oifice; US. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1965, no persons are required te respond to a collection of information uniess i displays a valid OMB conirel nurnber.
`
`TRANSMITTAL FOR POWER OF ATTORNEY TO ONE OR MORE
`REGISTERED PRACTITIONERS
`
`§ NOTE: This form is to be submitted with the Power of Attomey by Applicant form (PTO/AIA/82B) to identify the application to which the
`i Power of Attomeyis directed, in accordance with 37 CFR 1.5, unless the application number and filing date are identified in the Power of
`§ Attorney by Applicant form.
`if neither form PTO/AIA/82A sorform PTOV/AIA82B identifies the application to which the Powerof Attorney is
`directed, the Power of Attorney will noi be recognized in the application.
`
`First Named inventor
`
`: Jeroen Poeze
`
`: MULTI-STREAM DATA COLLECTION SYSTEM FOR NONINVASIVE
`| MEASUREMENT OF BLOOD CONSTITUENTS
`
`forms are submitted.
`
`SIGNATURE of Applicant or Patent Practitioner
`/Scott Cromar/
`Scott Cromar
`
`| Registration
`| Number
`
`| 65066
`
`| Title Gf Applicantis a
`juristic entity)
`
`|
`f
`1
`
`Applicant Name (if Applicant is a juristic entity)
`
`| f
`
`; MOTE: This form must be signed in accordance with 37 CFR 1.33. See 37 CFR 1.4(d) for signature requirements and certifications. lf
`f|more than one applicant, use multiple forms.
`
`*Total of
`
`4
`
`This collection of information is required by 37 CFR 1.131, 1.32, and 1.33. The information is required to obiain or retain a benefit by
`
`the public whichis to file and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR
`1.11 and 1.14. This catlectian is estimated ic take 3 minutes to cornplete, including gathering, preoaring, and submitting the completed
`application form to the USPTO. Timewill vary depending upon theindividual case. Any comments on the amount of time you require
`io complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and
`Trademark Office, U.S. Deparimeni of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR
`COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1480, Alexandria, VA 22313-1480,
`
`if you need assistance In completing the form, call 1-800-PTO-9199 and s
`
`f option 2.
`
`3
`
`
`
`A
`ede:
`o
`i
`PTOUAMVB2BIO7-12)
`;
`Dos Code: PA.. .
`Appraved for usethrough 11/30/2074. OMB 0661-C025
`Document Description: Power of Attorney
`U.S. Paient and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`
`ss
`it displays a valid OMB control number.
`Under the Paperwork Reduction Act of 1995, no persons are required to respondte a collection of in
`
`
`
`
`OR
`
`
`Ses
`
`SeoSoeRoESSERSNEeeeeESeNEKneeneesEEEsereEseoEERETeeEREESEEEEMNEEEESEEHNSREREEESEEEEEENESENEREENSSEREANEEEERREEERETEERREMEEEERNERAERENENONSEERRNANNNNT
`
`
`y
`pi
`p
`| hereby revoke ail
`previous
`powers of attorney given in ihe application identified in ine alfached transmittal letier.
`
`
`t
`
`with the following Customer Number as my/our attorney(s
`= i hereby appoint Prechiiones) associa
`inthe United States Patent atid Trademark Office connected therewith for the application referenced
`“transact all business
`in the attached tranemitta Jetter Gorm PTO/AIA/B2ah.or equivalent}
`
`
`
`Co i hereby appoint Practitioner(s) named belowas my/our attorney(s} or agent(s}, and to transact all business inthe
`oes“ United States Patent and Trademark Office connected therewith forthe application referenced in the attached
`
`transmittal letter (form PTO/AIA/824 or equivalent):
`
`
`Registration
`Registration
`
`Narmne
`
`
`
`glee
`Name
`Negeraus
`
`
`SoaooTSRNORAANDEMNRASCocraScatcAANNNONSERRCONTERRNNAANNNETTN
`Number
`Number
`
`Laced
`SOEISIE
`
`
`
` SRIRAM RAAT
`LAAALULLLEAWAAARLIIAARALAAASAAULLALAARASICAAAAAAARAAAAAAINARLQARISLARASABACIARANIRAAANANARAAAR
`
`
`PINARTANFTRESS AANARS
`
`
` SpaoreRSHRSECAR COCR
`coRCKER,
`SCECCAESECOARSER
`y
`
`
`
`OANA OANAAALSAARRASCALSLCAASAIOAAOA SSAA
`Piease recognize or change the Correspondence address for ihe anplication identified in the attached
`transmittal letterta:
`Teoma
`The address associated with the above-mentioned Customer Number,
`
`
`+
`| The address associated with Customer Number:
`
`
`
`
`i
`
`
`
`
` Felephone
`
`Feleptionea sossgcsimmammmananisnsnmniinanisnanmmrnnnmnrnmnmnnntslttall[ccm
`
`
`Van the Applicant:
`
`
`
`
`i|_jinverttor or Joint inventor
`actated Inventor
`
`
`
`Hf Assignee or Person to Whara the Inventor is Under an Obligation te Assign
`"|Person Who Otherwise Shows Sufficient Froprietary interest (e.g., a petition under 37 GFR 146(b\(2) was
`
`
`granted in ihe application or is concurrently being fled with this document}
`
`sonsonnsronnpogopnnaeeaasstsensesntnangRORRREOUDOTSODOURSNESNORDEAAAASAfinniinnnnaaanaansanananananhahahahhhhheee .
`SIGNATURE of Applicant for Patent
`a
`
`i$
`
`+ c
`
`
` SSAASSSSSE!
`walleand Company1S
`
`:: Signature = This form must be sig
`in accordance with. 37 CFR 133. See 37 CFR 1.4 for signature requirements and
`ad by the applicant
`
`certifications. Submit multioie forme for more than one signature, see below *;
`SOTERAANIASAASANPLIESNARReeODOUR
`easy,
`1
`.
`
`
`Le*Total ot? __ forms are submitted.
`
`SLANE
`
`
`enefit by the public whichdsto file (and by the
`
`
`fon is estimatedto. take 3minutes ‘o comptate,
`
`ding sj
`yt
`3 oationsfifor voducing this hurdan,"shouid be sent to the .chiefftiforsredtion offeer, ‘U,5. Bater
`‘ahd
`mount of
`tim
`i recuse: to complete this foi “anulor
`
`
`
`Trademark Office, US. Department of Conimerce, P.O. Box
`1450,-Alexundiia, VA 22319-1450, [0 NOT SEND FEES C3 COMPLETED FORMS TO THIS
`ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1480, Alexandria, VA 22313-1466.
`
`if you need assistance in completing the form, call 1-800-PTO-9799 and selact optic,
`
`4
`
`
`
`Docket No.: MASCER.002C4
`App. No.:
`Unknown
`Please Direct All Correspondence to Customer Number 64735
`
`December6, 2018
`Page 1 of 1
`
`RESCISSION OF ANY PRIOR DISCLAIMERS AND REQUEST TO REVISIT ART
`
`Inventor
`
`:
`
`Jeroen Poeze
`
`App. No
`
`>: Unknown
`
`Filed
`
`For
`
`: Herewith
`
`> MULTI-STREAM DATA COLLECTION SYSTEM FOR
`NONINVASIVE MEASUREMENT OF BLOOD CONSTITUENTS
`
`Examiner
`
`: Unknown
`
`Art Unit
`
`: Unknown
`
`>: Unknown
`Conf #
`
`
`Commissioner for Patents
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`Dear Commissioner:
`
`The claims of the present application are different and possibly broader in scope than the
`
`claims pursued in the parent application(s).
`
`To the extent any prior amendments or
`
`characterizations of the scope of any claim or referenced art could be construed as a disclaimer of
`
`any subject matter supported by the present disclosure, Applicant hereby rescinds and retracts
`
`such disclaimer. Accordingly, the references previously considered in the parent application(s)
`
`may necdto be re-visited.
`
`Knobbe, Martens, Olson & Bear, LLP
`
`Respectfully submitted,
`
`{Scott Cromatr/
`Scott A. Cromar
`Registration No. 65,066
`Registered Practitioner
`Customer No. 64735
`(949) 760-0404
`
`Dated: December6, 2018
`
`29531470
`
`5
`
`
`
`Miscellaneous-Filing:
`
`660
`
`760
`
`4000
`
`400
`
`6
`
`60
`
`760
`
`4000
`
`400
`
`1
`
`1 1
`
`1
`
`1311
`
`1817
`
`UTILITY APPL SIZE FEE PER 50 SHEETS >100
`
`Electronic Patent Application Fee Transmittal
`
`Filing Date:
`
`Title of Invention:
`
`MULTI-STREAM DATA COLLECTION SYSTEM FOR NONINVASIVE
`MEASUREMENT OF BLOOD CONSTITUENTS
`
`First NamedInventor/Applicant Name:
`
`Jeroen Poeze
`
`Attorney Docket Number:
`
`MASCER.002C4
`
`Filed as Large Entity
`
`Filing Fees for Track | Prioritized Examination - Nonprovisional Application under 35 USC 111(a)
`
`Sub-Total in
`Amount
`Quantity
`Fee Code
`Description
`USD($)
`
`Basic Filing:
`
`300
`300
`UTILITY APPLICATION FILING
`
`
`UTILITY SEARCH FEE
`
`UTILITY EXAMINATION FEE
`
`REQUEST FOR PRIORITIZED EXAMINATION
`
`
`
`
`
`6
`
`
`
`Description
`
`Fee Code
`
`antit
`
`Sub-Total in
`
`PROCESSING FEE, EXCEPT PROV. APPLS
`
`1830
`
`1
`
`140
`
`140
`
`Total in USD (S$)
`
`Patent-Appeals-and-Interference:
`
`Post-Allowance-and-Post-Issuance
`
`Extension-of-Time:
`
`Miscellaneous:
`
`7
`
`
`
`
`
`aa
`
`Utility under 35 USC 111{a)
`Application Type:
`
`
`Paymentinformation:
`
`37 CFR 1.17 (Patent application and reexamination processing fees)
`
`Deposit Account
`
`111410
`
`The Director of the USPTO is hereby authorized to charge indicated fees and credit any overpayment as follows:
`37 CFR 1.16 (National application filing, search, and examination fees)
`
`Electronic AcknowledgementReceipt
`
`Title of Invention:
`
`MULTI-STREAM DATA COLLECTION SYSTEM FOR NONINVASIVE
`MEASUREMENT OF BLOOD CONSTITUENTS
`
`First Named Inventor/Applicant Name:
`
`Jeroen Poeze
`
`Customer Number:
`
`64735j=
`a
`
`ee
`
`8
`
`
`
`
`
`Pages
`Multi
`File Size(Bytes)/
`Document Description
`Document
`
`
`
`Number Message Digest|Part /.zip|P (if appl.)
`1257993
`
`
`
`Information:
`
`Application Data Sheet
`
`ADS_MASCERO002C4.pdf
`
`cOfdada4d3d8d3b0966d8f626737257BG
`d9c21
`
`353155
`
`SPEC_MASCERO02C4.pdf
`
`DocumentDescription
`
`Specification
`
`Claims
`
`Abstract
`
`a64d0
`
`
`
`Warnings:
`Information:
`
`1408181
`
`Drawings-other than black and white
`.
`.
`line drawings
`
`FIGS_MASCER002C4.pdf
`
`453e36dd08fca7a9e351 0bcdea4becc04bfal
`288c
`
`Warnings:
`Information:
`
`Information:
`
`TrackOne Request
`
`TRACK1_MASCERO02C4.pdf
`
`4052672c..2123.d2.0542a3579e4209018
`2e5
`
`128335
`
`Powerof Attorney
`
`POA_MASCER002C4.pdf
`
`2995c3a6a87f1 da7d3b0a9ch0b96b45944al
`
`527667
`
`9
`
`
`
`Information:
`
`Miscellaneous Incoming Letter
`
`RESC_MASCERO02C4.pdf
`
`d4eS5ade8e647d43aad21 74a79a12601ab8
`O4aca
`
`
`
`Warnings:
`Information:
`
`
`
`the application.
`
`New Applications Under 35 U.S.C. 111
`If a new applicationis being filed and the application includes the necessary componentsfora filing date (see 37 CFR
`1.53(b)-(d) and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date shownon this
`Acknowledgement Receiptwill establish thefiling date of the application.
`National Stage of an International Application under 35 U.S.C. 371
`If a timely submission to enter the national stage of an international application is compliant with the conditions of 35
`U.S.C. 371 and other applicable requirements a Form PCT/DO/EO/903indicating acceptance of the application as a
`national stage submission under35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.
`New International Application Filed with the USPTO asa Receiving Office
`If a new international application is being filed and the international application includes the necessary components for
`an international filing date (see PCT Article 11 and MPEP 1810), a Notification of the International Application Number
`andof the International Filing Date (Form PCT/RO/105)will be issued in due course, subject to prescriptions concerning
`national security, and the date shown on this Acknowledgement Receiptwill establish the international filing date of
`
`Fee Worksheet (SB06)
`
`fee-info.pdf
`
`618d5743f9781 a0d878917e11 Ocafd8505ec]
`
`Information:
`
`This Acknowledgement Receipt evidences receipt on the noted date by the USPTOofthe indicated documents,
`characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt similar to a
`Post Card, as described in MPEP 503.
`
`10
`
`10
`
`
`
`PTO/AIA/14 (02-18)
`Approved for use through 11/30/2020. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit contains a valid OMB control number.
`
`icati
`Application Data Sheet 37 CFR 1.76
`Application Number
`MULTI-STREAM DATA COLLECTION SYSTEM FOR NONINVASIVE MEASUREMENT OF BLOOD
`
`Title of Invention
`
`CONSTITUENTS
`
`The application data sheetis part of the provisional or nonprovisional application for which it is being submitted. The following form contains the
`bibliographic data arrangedin a format specified by the United States Patent and Trademark Office as outlined in 37 CFR 1.76.
`This document may be completed electronically and submitted to the Office in electronic format using the Electronic Filing System (EFS) or the
`document maybe printed and included in a paperfiled application.
`
`Secrecy Order 37 CFR5.2:
`
`Oo Portionsorall of the application associated with this Application Data Sheet mayfall under a Secrecy Order pursuantto
`
`37 CFR 5.2 (Paper filers only. Applications that fall under Secrecy Order may notbefiled electronically.)
`
`Inventor Information:
`
`
`Middle Name
`
`
`
`ResidenceInformation (Select One)
`@ US Residency
`Non US Residency
`Active US Military Service
`
`|city|| Rancho Santa Margarita State/Province | Pa|Country of Residencd
`
`
`Mailing Addressof Inventor:
`fAddresst||
`Address?
`
`
`|city |R ancho Santa Margarita State/Province
`PPosiaGode[pos[Covi[ps
`enebo
`Legal Name
`
`[Pret]GivenName‘(|MiddleName(|FamilyName———_*|Sun
`THfeccsSs Se
`Residence Information (Select One)
`(@) US Residency
`Non US Residency
`Active US Military Service
`
`
`
`
`Mailing Addressof Inventor:
`
`Address 1
`
`0292 Orange Avenue
`
`Address 2
`
`city| Puverino__] StateProvince
`[Pa
`
`Postal Code
`i
`| US
`
`Inventor
`Ri
`PeSreeneeaneenene| a
`
`Legal Name
`
`Active US Military Service
`Non US Residency
`(@) US Residency
`ResidenceInformation (Select One)
`
`
`EFS Web 2.2.13
`
`11
`
`11
`
`
`
`PTO/AIA/14 (02-18)
`Approved for use through 11/30/2020. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit contains a valid OMB control number.
`
`Attorney Docket Number|MASCER.002C4 Application Data Sheet 37 CFR 1.76
`
`Application Number
`
`Title of Invention
`
`MULTI-STREAM DATA COLLECTION SYSTEM FOR NONINVASIVE MEASUREMENT OF BLOOD
`CONSTITUENTS
`
`
`
`
`
`
`
`
`Middle Name
`
`Residence Information (Select One)
`(@) US Residency
`Non US Residency
`Active US Military Service
`
`|city|| State/Province [Fa|Country of Residencd [ps
`
`
`
`
`Mailing Addressof Inventor:
`Address 1
`| p3972 Oswego St.
`
`[PostalGode[BRO——SSCSC~iduty
`Inventor
`Legal Name
`
`Prefix} Given Name
`
`Middle Name Family Name
`
`Residence Information (Select One)
`
`(@) US Residency
`
`Non US Residency
`
`
`
`Active US Military Service
`
`
`Mailing Addressof Inventor:
`
`! 8849TetonCir
`Address 1
`
`
`Address 2|city|| Fountaina State/Province
`
`
`
`Remove
`
`
`
`Legal Name
`
`Prefix| Given Name
`Middle Name
`Family Name
`Bruinsma
`@ Non US Residency
`
`Residence Information (Select One) () US Residency
`
`Active US Military Service
`
`||[+
`
`EFS Web 2.2.13
`
`12
`
`12
`
`
`
`PTO/AIA/14 (02-18)
`Approved for use through 11/30/2020. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit contains a valid OMB control number.
`
`
`Attorney Docket Number|MASCER.002C4
`Application Data Sheet 37 CFR 1.76
`Application Number
`MULTI-STREAM DATA COLLECTION SYSTEM FOR NONINVASIVE MEASUREMENT OF BLOOD
`CONSTITUENTS
`
`Title of Invention
`
`fAdaresst|feesimwanseasCd
`Address?[|
`rciy| prene———SSCSCSCSCS—~SStaterrovince
`PostalCode|faieRT————SCSC~domy
`
`Inventor
`Legal Name
`
`
`Mailing Addressof Inventor:
`
`Address 2
`
`
`ity|| rvine State/Province
`
`[PosiGod[ETcounty[5
`menebo
`Legal Name
`
`i|c
`
`Prefix) Given Name
`
`Middle Name
`
`
`Family Name
`
`
`
`Prefix) Given Name
`LoFed
`Residence Information (Select One)
`(@) US Residency
`(©) Non US Residency
`Active US Military Service
`roiy[fone ___——_—_—* StatProvince[pa]CountyofResidenes[PS _———d
`
`
`Family Name
`
`
`Middle Name
`
`
`
`
`
`
`i
`| 92677
`Postal Code
`
`Inventor
`§
`Legal Name
`
`
`
`Address 2|city| aguna—L State/Province | EA
`
`
`
`eelSeenReneeaveamasTe
`
`TTHbDendO
`
`Residence Information (Select One)
`(@) US Residency © Non US Residency
`Active US Military Service
`EFS Web 2.2.13
`
`13
`
`13
`
`
`
`PTO/AIA/14 (02-18)
`Approved for use through 11/30/2020. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit contains a valid OMB control number.
`
`Attorney Docket Number|MASCER.002C4
`Application Data Sheet 37 CFR 1.76
`—
`Application Number
`
`Title of Invention
`MULTI-STREAM DATA COLLECTION SYSTEM FOR NONINVASIVE MEASUREMENT OF BLOOD
`CONSTITUENTS
`
`
`
`State/Province
`
`Country of Residencd
`
`
`Mailing Addressof Inventor:
`
`Address 1
`
`Address 2
`
`8842 Vista Portola
`
`city[[ratucoCanyonSSSS—~=*di*StatevProvince | FA
`
`Postal Code
`| US
`All
`Inventors Must Be Listed - Additional
`Inventcor Information blocks may be
`generated within this form by selecting the Add button.
`
`
`
`
`
`
`Correspondence Information:
`
`Enter either Customer Number or complete the Correspondence Information section below.
`For further information see 37 CFR 1.33(a).
`
`[] An Addressis being provided for the correspondenceInformation of this application.
`Customer Number
`| Ba735
`
`
`
`
`
`Application Information:
`
`Application Type|onprovional
`Subject Matter a
`
`
`
`Total Numberof Drawing Sheets(if any)SuggestedFigureforPublication(ifany)||_||65|
`
`Filing By Reference:
`
`Only complete this section whenfiling an application by reference under 35 U.S.C. 111(c) and 37 CFR 1.57(a). Do not completethis sectionif
`application papers including a specification and any drawings are being filed. Any domestic benefit or foreign priority information must be
`provided in the appropriate section(s) below (i.e., "Domestic Benefit/National Stage Information” and “Foreign Priority Information”).
`
`For the purposesofa filing date under 37 CFR 1.53(b), the description and any drawings of the present application are replaced by this
`reference to the previouslyfiled application, subject to conditions and requirements of 37 CFR 1.57(a).
`i
`
`Application numberof the previously
`Filing date (YYYY-MM-DD)}
`Intellectual Property Authority or Country
`filed application
`
`Po
`
`
`publication at eighteen months afterfiling. EFS Web 2.2.13
`
`Request Not to Publish. | hereby requestthat the attached application not be published under
`35 U.S.C. 122(b) and certify that the invention disclosed in the attached application has not and will not be the
`subject of an application filed in another country, or under a multilateral international agreement, that requires
`
`Publication Information:
`
`
`
`
`
`Request Early Publication (Fee required at time of Request 37 CFR 1.219)
`
`14
`
`14
`
`
`
`PTO/AIA/14 (02-18)
`Approved for use through 11/30/2020. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit contains a valid OMB control number.
`
`Attorney Docket Number|MASCER.002C4
`Application Data Sheet 37 CFR 1.76
`Application Number
`MULTI-STREAM DATA COLLECTION SYSTEM FOR NONINVASIVE MEASUREMENT OF BLOOD
`
`Title of Invention
`
`CONSTITUENTS
`
`Representative Information:
`
`Representative information should be provided for all practitioners having a power of attorney in the application. Providing
`this information in the Application Data Sheet does not constitute a powerof attorney in the application (see 37 CFR 1.32).
`Either enter Customer Number or complete the Representative Name section below.
`If both sections are completed the customer
`Numberwill be used for the Representative Information during processing.
`
`
` Please Select One:
`
`US Patent Practitioner
`
`©) Limited Recognition (37 CFR 11.9)
`
`e@ Customer Number
`
`Domestic Benefit/National Stage Information:
`
`
`This section allows for the applicant to either claim benefit under 35 U.S.C. 119(e), 120, 121, 365(c), or 386(c) or indicate
`
`
`National Stage entry from a PCT application. Providing benefit claim information in the Application Data Sheet constitutes
`the specific reference required by 35 U.S.C. 119(e) or 120, and 37 CFR 1.78.
`When referring to the current application, please leave the “Application Number”field blank.
`
`
`
`
`
`Filing or 371(c) Date
`
`
`
`Application Number
`Continuity Type
`Prior Application Number
`(YYYY-MM-DD)
`
`
`
`
`
`
`Coee
`
`2015-12-28
`Application
`Prior—— wryDate
`IssueDate
`Prior Application Status [Patented[Remove|
`
`
`
`
`
`
`Number
`Continuity Type
`YYYY-MM-DD)
`Patent Number
` (YYYY-MM-DD)|[141981290 |Continuationof|_|}/12/820352 Pi010-07-01 |277880 |po16-03-08
`
`
`
`
`
`
`
`Filing or 371(c) Date
`
`
`Prior Application Number
`(YYYY-MM-DD)
`
`
`
`
` 2009-08-03
`
`
`Remove
`
`
`
`
`Filing or 371(c) Date
`
` Prior Application Number
`(YYYY-MM-DD)
`
`
`
`
`| laims benefit of provisional
`| 2/534827
`-| 61/086060
`2008-08-04
`
`
`ApplicationStatus| Fxpired[Remove|weedor 371(c) Date|PriorApplicationStatus|Application Status|Prior
`
`
`
`
`Application Number
`
`Continuity Type
`
`Application Number
`
`Continuity Type
`
`Application Number
`Continuity Type
`
`|fizssae27ns3ae27 laims benefit of provisional
`
`
`
`Prior Application Number
`-| 61/086108
`
`(YYYY-MM-DD)
`
`
`|poos-08-04poos.8-0408-04
`
`EFS Web 2.2.13
`
`15
`
`15
`
`
`
`PTO/AIA/14 (02-18)
`Approved for use through 11/30/2020. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit contains a valid OMB control number.
`Attorney Docket Number|MASCER.002C4
`Application Data Sheet 37 CFR 1.76
`Application Number
`MULTI-STREAM DATA COLLECTION SYSTEM FOR NONINVASIVE MEASUREMENT OF BLOOD
`CONSTITUENTS
`
`Application Number
`
`Continuity Type
`
`
`
`
`
`
`
`Title of Invention
`
`
`
` Remove
`
`Filing or 371(c) Date
`
`
`Prior Application Number
`
`(YYYY-MM-DD)
`
`
`
`
`-| 61/086063
`2008-08-04
`| 2/534827
`| laims benefit of provisional
`
`
`
`Filing or 371(c) Date
`
`(YYYY-MM-DD)
`Prior Application Number
`Continuity Type
`Application Number
`2008-08-04
`-| 61/086057
`| laims benefit of provisional
`| 2/534827
`
`
`
`
`Prior Application Status [Exvired
`Remove
`
`
`
`Filing or 371(c) Date
`
`
`
`Continuity Type
`Application Number
`(YYYY-MM-DD)
`Prior Application Number
`
`
`
`
`
`
`
`
`| 21534827 |*] 61/091732|2008-08-25| laims benefit of provisional
`
`
`Issue Date
`Filing Date
`Prior Application
`Application
` Continuity Type
`
`
`Number (YYYY-MM-DD)|PatentNumber|(yyyy-MM-DD)Number
`
`2013-11-03
`12/829352
`4h07-02
`p577431
`
`
`
`
`
`
`
`
`
`Filing or 371(c) Date
`
`Application Number
`(YYYY-MM-DD)
`Prior Application Number
`
`| 21497528
`2008-08-04
`-| 61/086060
`
`
`
`
`
`
`
`
`
`
`Filing or 371(c) Date
`
`
`
`Continuity Type
`Application Number
`(YYYY-MM-DD)
`
`
`
`
`
`
`| 2497528 |+] 61/086108|2008-08-04| laims benefit of provisional
`
`
`
`
`Filing or 371(c) Date
`
`
`
`Application Number
`(YYYY-MM-DD)
`Prior Application Number
`
`
`
`
`
`
`| 2/497528
`2008-08-04
`
`
`
`Filing or 371(c) Date
`
`
`
`Continuity Type
`Application Number
`Prior Application Number
`(YYYY-MM-DD)
`
`
`
`
`
`| laims benefit of provisional
`| 31497528
`|-| 61/086057
`
`2008-08-04
`Remove
`Prior Application Status fprired
`
`
`
`Filing or 371(c) Date
`
`(YYYY-MM-DD)
`Prior Application Number
`
`
`2008-07-03
`| 61/078228
`
`
`
`
`Remove
`
`Continuity Type
`| laims benefit of provisional
`
`Prior Application Number
`
`
`
`Continuity Type
`| laims benefit of provisional
`
`| 61/086063
`
`
`
`
`
`
`
`
`
`Application Number
`| 2/497528
`
`Continuity Type
`| laims benefit of provisional
`
`EFS Web 2.2.13
`
`16
`
`16
`
`
`
`PTO/AIA/14 (02-18)
`Approved for use through 11/30/2020. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit contains a valid OMB control number.
`
`Attorney Docket Number|MASCER.002C4
`Application Data Sheet 37 CFR 1.76
`Application Number
`MULTI-STREAM DATA COLLECTION SYSTEM FOR NONINVASIVE MEASUREMENT OF BLOOD
`CONSTITUENTS
`
`Application Number
`
`
`| 2/497528
`
`Continuity Type
`
`| laims benefit of provisional
`
`Application
`
`.
`
`Prior Application
`
`Filing Date
`
`Issue Date
`
`Title of Invention
`
`
`
` Remove
`
`Filing or 371(c) Date
`
`
`Prior Application Number
`
`(YYYY-MM-DD)
`
`
`
`-| 61/078207
`2008-07-03
`
`
`
`
`
`Filing or 371(c) Date
`
`(YYYY-MM-DD)
`Prior Application Number
`Continuity Type
`Application Number
`2008-08-25
`-| 61/091732
`| laims benefit of provisional
`| 2/497528
`
`
`
`
`
`Prior Application Status [Patented
`Remove
`
`
`
`
` Issue Date
`
` Filing Date
`Application
`Prior Application
`Patent Number
`
`
`
`Continuity Type
`(YYYY-MNM-DD)
`
`2008-08-25 1D621516
`b010-08-10
`
`
`
`
`
`
`|pooe-12-22
`|12/497528
`| ontinuation in part of +| povs23408
`|poos-08-25
`|peosesa
`
`
`
`
`Issue Date
`Filing Date
`Prior Application
`Application
`
`
`
`Continuity Type
`Number Patent Number=)(yyyy-MM-DD)Number (YYYY-MM-DD)
`
`
`
`
`poo9-07-02 437825 2013-05-07
`12/829352
`
`
`
`
`
`
` Remove
`
`
`
`Filing or 371(c) Date
`
`(YYYY-MM-DD)
`
`
`
`
`| 21497523 + 61/086060|2008-08-04| laims benefit of provisional
`
`
`
`
`
`
`
`Filing or 371(c) Date
`
`
`
`Application Number
`Continuity Type
`(YYYY-MM-DD)
`
`
`
`
`
`
`| 21497523 |~| 61/086108|2008-08-04| laims benefit of provisional
`
`
`Filing or 371(c) Date
`
`
`
`(YYYY-MM-DD)
`Prior Application Number
`Application Number
`
`
`-| 61/086063
`2008-08-04
`| 2/497523
`
`
`
`
`Filing or 371(c) Date
`
`
`
`(YYYY-MM-DD)
`Prior Application Number
`
`
`-| 61/086057
`2008-08-04
`
`
`Application Number
`
`Continuity Type
`
`
`
`
`Prior Application Number
`
`Prior Application Number
`
`Continuity Type
`| laims benefit of provisional
`
`Application Number
`| 2/497523
`
`Continuity Type
`| laims benefit of provisional
`
`EFS Web 2.2.13
`
`17
`
`17
`
`
`
`PTO/AIA/14 (02-18)
`Approved for use through 11/30/2020. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit contains a valid OMB control number.
`
`Attorney Docket Number|MASCER.002C4
`
`Application Data Sheet 37 CFR 1.76
`Application Number
`MULT